HOME  >  Online journal

Vol.62 No.7 contents

Japanese/English

Full Text of PDF (497K) Article in Japanese

- Original Article -

Usefulness of the High-sensitivity Lung Cancer Compact Panel™ with Cytological Specimens

Daisuke Minami^1,2, Nagio Takigawa^3,4, Akio Tada¹, Yasuhiro Nakajima¹, Nobuaki Miyahara³, Yasuyuki Mizumori⁵, Mitsuhiro Ueda⁶, Yoshiharu Sato⁷, Kei Morikawa⁸, Arihiko Kanehiro^3
1Department of Respiratory Medicine, Himeji Saint Mary's Hospital, Japan, ²Department of Respiratory Medicine, Hosoya Hospital, Japan, ³Department of Internal Medicine, Himeji Saint Mary's Hospital, Japan, ⁴Department of Internal Medicine 4, Kawasaki Medical School, Japan, ⁵Department of Respiratory Medicine, ⁶Department of Thoracic Surgery, National Hospital Organization Himeji Medical Center, Japan, ⁷DNA Chip Research Inc., Japan, ⁸Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Japan

---

Objective. We verified the usefulness of a new next-generation sequencing modality with the Lung Cancer Compact Panel™ using cytological specimens. Study Design. From December 2021 to February 2022, the wash fluid of lung tumors from 10 patients obtained using endobronchial ultrasonography (EBUS) with a guide sheath (GS), EBUS transbronchial needle aspiration (EBUS-TBNA), and pleural effusion puncture was examined with the Lung Cancer Compact Panel™. We examined the patients' medical records to obtain information on the analysis success rate and detection rate of gene mutations in consecutive cases searched for driver gene mutations. Results. Ten patients (6 lung adenocarcinoma, and 1 each of lung squamous cell carcinoma, small-cell lung cancer, renal cell carcinoma, and organizing pneumonia) and 12 samples (7 from brushing, 2 from EBUS-TBNA, 1 from a transbronchial biopsy [TBB] plus brushing, 1 from a TBB, and 1 from brushing) were examined using the Lung Cancer Compact Panel™. We successfully analyzed all tests in all 10 patients (100%). EGFR L858R, KRAS G12D, or KRAS G12V was detected in lung adenocarcinoma patients. KRAS G12V was detected in the lung squamous cell carcinoma patient. The amounts of nucleic acids from the pleural effusion puncture and EBUS-TBNA were sufficient for the analyses. Conclusion. The Lung Cancer Compact Panel™ was useful for detecting gene mutations using cytological specimens.
key words: Lung Cancer Compact Panel™, Next-generation sequencing, Cytological specimen

Received: June 2, 2022
Accepted: August 2, 2022

JJLC 62 (7): 989-995, 2022